Skip to main content
. 2011 Jan 27;6:10. doi: 10.1186/1748-717X-6-10

Table 2.

Plan characteristics

Meningioma EQD22 (Gy) Pituitary adenoma EQD210 (Gy)
No of plan 11 10
Tumor
Volume of PTV
(cm3)
8.06 ± 2.45
9.53 ± 1.75
Prescribed dose 5 30 Gy/5 fr. 40 4 25 Gy/5 fr. 31.3
1 16 Gy/1 fr. 34.6 2 21 Gy/3 fr. 29.8
1 21 Gy/3 fr. 29.8 1 22.5 Gy/3 fr. 32.8
1 24 Gy/5 fr. 29.6 2 24 Gy/5 fr. 29.6
1 23 Gy/3 fr. 33.9 1 24 Gy/3 fr. 36
1 24 Gy/3 fr. 36
s
Minimal dose/prescribed dose
(%)
83.7 ± 9 range 72 - 90
80 ± 12 range 60 - 99
Maximal dose/prescribed dose
(%)
122 ± 15 range 110 - 157
129 ± 17 range 105 - 157
OARs
(Gy)
Left eye 0.12 - 2.25 0.02 - 4.48
Right eye 3.07 - 18.6 0.05 - 4.52
Brain stem 4.97 - 15.4 4.5 - 19.5 17.3 - 24.74 30.0 - 42.9
Optic chiasm 4.61 - 15.4 4.1 -- 19.9 16.6 - 26.4 22 -- 48
Left lens 0.01 - 2.00 0.03 - 4.08
Right lens 0.88 - 6.68 0.13 - 3.81
Left optic nerve 0.79 - 8.96 0.4 - 8.5 12.4 - 23.4 23 - 50
Right optic nerve 7.93 -- 26.4 14.6 - 47.9 0.37 - 23.4 17.5 -- 57.5

EQD2 = n × d × (α/β+d)/(α/β+2), EQD210; α/β = 10 for PTV and EQD22; α/β = 2 for organs at risk

OARs; organs at risk, fr.; fraction